Stem Cell Therapy Market worth $615 million by 2028

The stem cell therapy market is projected to reach USD 615 million by 2028 from USD 286 million in 2023, at a CAGR of 16.5% during the forecast period
Stem Cell Therapy Market [https://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html?utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $286 million in 2023 and is poised to reach $615 million by 2028, growing at a CAGR of 16.5% from 2023 to 2028 according to a new report by MarketsandMarkets. The global stem cell therapy market is expected to grow at a CAGR of 16.8% during the forecast period. The major factors driving the growth of the market are expanding number of clinical trials of stem cell therapies, rise in stem cell research funding and growing number of GMP-certified cell therapy production facilities. However, high costs associated with the development of stem cell therapy and treatment is anticipated to hamper the market growth in coming years.

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48 [https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48&utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral]

The adipose tissue derived MSCs segment dominated the stem cell therapy market in 2022.

The global stem cell therapy market is segmented into adipose tissue-derived MSCs, bone marrow-derived MSCs, placenta/umbilical cord-derived MSCs, and other cell sources. Prominent factors such as easy availability of adipose-derived stem cell tissues and its diversified properties properties similar to other mesenchymal stem cells/tissues is likely to uplift the demand for adipose tissue derived MCs.

In 2022, the musculoskeletal disorders led the stem cell therapy market.

Based on therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds & surgeries, cardiovascular diseases, surgeries, inflammatory & autoimmune diseases, neurological disorders, and other therapeutic applications. The large share of this segment can be attributed increasing prevalence of musculoskeletal diseases. Increasing investment in stem cell therapy for neurological diseases is likely to skyrocket the segment in coming years.

The Asia Pacific region is likely to grow at faster pace during the forecast period.

The Asia Pacific is estimated to be the fastest-growing segment of the market. The growth of the stem cell therapy markets in the region is driven by a rising emphasis on strategic initiatives such as partnerships, collaborations & expansion and increased adoption of stem cell therapies among the patient population. The rising prevalence of cancer and increased investment in research & development of the launch of novel stem cell therapies in the region are some of the major factors anticipated to upsurge the market growth.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=48 [https://www.marketsandmarkets.com/requestsampleNew.asp?id=48&utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral]

Stem Cell Therapy Market Dynamics:

Drivers:

1. Increased funding for stem cell research

Restraints:

1. Ethical concerns related to embryonic stem cells

Opportunities:

1. The emergence of iPSCs as an alternative to ESCs

Challenge:

1. Technical limitations

Key Market Players of Stem Cell Therapy Industry:

The stem cell therapy market is competitive, with a small number of players competing for market shares. Smith+Nephew (UK), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), CORESTEM (South Korea), Pharmicell Co., Ltd. (South Korea), NuVasive, Inc. (US), RTI Surgical (US), AlloSource (US), JCR Pharmaceuticals Co., Ltd. (Japan), Takeda Pharmaceutical Company Limited (Japan), Holostem Terapie Avanzate Srl (Italy), Orthofix (US), Regrow Biosciences Pvt Ltd. (India), and STEMPEUTICS RESEARCH PVT LTD. (India) among others are some of the leading players in this market. Most companies in the market focus on organic and inorganic growth strategies, such as product launches, expansions, acquisitions, partnerships, agreements, and collaborations, to increase their product offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

The primary interviews conducted for this report can be categorized as follows:

* By Respondent: Supply Side- 80%, and Demand Side - 20%
* By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
* By Region: North America -40%, Asia-Pacific -20%, Europe -30%, ROW-10%

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=48 [https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=48&utm_source=Abnewswire&utm_campaign=Paid&utm_content=Referral]

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=stem-cell-therapy-market-worth-615-million-by-2028]
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/stem-cell-technologies-and-global-market-48.html



This release was published on openPR.